Drug profile · INN
interferon beta-1b
BETAFERON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
interferon beta-1b (BETAFERON) is an FDA-listed pharmaceutical active ingredient. Associated with Bayer Australia Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN interferon beta-1b
Brand BETAFERON
Route SUBCUTANEOUS
Formulation VIAL
ATC code L03AB08
Originator Bayer Australia Ltd
Frequently asked questions
What is interferon beta-1b?
interferon beta-1b (BETAFERON) is an FDA-listed pharmaceutical active ingredient. Associated with Bayer Australia Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for interferon beta-1b?
BETAFERON is a marketed brand name for interferon beta-1b. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of interferon beta-1b?
interferon beta-1b has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.